SCIENCE@home

Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study

H. Vrijmoeth,J. Ursinus,M. Harms,A. D. Tulen,M. Baarsma,F. R. van de Schoor,S. A. Gauw,T. Zomer,Y. Vermeeren,J. A. Ferreira,Hein Sprong,Kristin Kremer,H. Knoop,L. Joosten,B. Kullberg,J. Hovius,C. C. van den Wijngaard

Published 2023 in EBioMedicine

ABSTRACT

Summary Background Patients treated for Lyme borreliosis (LB) frequently report persistent symptoms. Little is known about risk factors and etiology. Methods In a prospective observational cohort study with a follow-up of one year, we assessed a range of microbiological, immunological, genetic, clinical, functional, epidemiological, psychosocial and cognitive-behavioral variables as determinants of persistent symptoms after treatment for LB. Between 2015 and 2018 we included 1135 physician-confirmed LB patients at initiation of antibiotic therapy, through clinical LB centers and online self-registration. Two reference cohorts of individuals without LB (n = 4000 and n = 2405) served as a control. Prediction analyses and association studies were used to identify determinants, as collected from online questionnaires (three-monthly) and laboratory tests (twice). Findings Main predictors of persistent symptoms were baseline poorer physical and social functioning, higher depression and anxiety scores, more negative illness perceptions, comorbidity, as well as fatigue, cognitive impairment, and pain in 295 patients with persistent symptoms. The primary prediction model correctly indicated persistent symptoms in 71.0% of predictions (AUC 0.79). In patients with symptoms at baseline, cognitive-behavioral responses to symptoms predicted symptom persistence. Of various microbiological, immunological and genetic factors, only lower IL-10 concentrations in ex vivo stimulation experiments were associated with persistent symptoms. Clinical LB characteristics did not contribute to the prediction of persistent symptoms. Interpretation Determinants of persistent symptoms after LB were mainly generic, including baseline functioning, symptoms and cognitive-behavioral responses. A potential role of host immune responses remains to be investigated. Funding 10.13039/501100001826Netherlands Organisation for Health Research and Development (ZonMw); the 10.13039/501100002999Dutch Ministry of Health, Welfare and Sport (VWS).

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-55 of 55 references · Page 1 of 1

CITED BY

Showing 1-27 of 27 citing papers · Page 1 of 1